CD90(+)CD45(-) intraperitoneal mesothelial-like cells inhibit T cell activation by production of arginase I

Cellular Immunology

Volumn 288, Issue 1, 2014, Pages 8-14

  Kitayama, Joji ^a   Emoto, Shigenobu ^a   Yamaguchi, Hironori ^a   Ishigami, Hironori ^a   Yamashita, Hiroharu ^a   Seto, Yasuyuki ^a   Matsuzaki, Keisuke ^a   Watanabe, Toshiaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arginase; Immunosuppression; Mesothelial cell; Peritoneal cavity; T cell

Indexed keywords

ARGINASE; IMMUNOSUPPRESSION; MESOTHELIAL CELL; PERITONEAL CAVITY; T CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, THY-1; ARGINASE; ARGININE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; PERITONEAL CAVITY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84894094878     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.01.008     Document Type: Article

References (37)

1. Davidson B. Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature. Anal. Cell. Pathol. 2001, 23:107-128.
2. Rodriguez E.F., Monaco S.E., Khalbuss W., Austin R.M., Pantanowitz L. Abdominopelvic washings: a comprehensive review. Cytojournal 2013, 10:7.
3. Cailleau R., Mackay B., Young R.K., Reeves W.J. Tissue culture studies on pleural effusions from breast carcinoma patients. Cancer Res. 1974, 34:801-809.
4. Whitehead R.H., Hughes L.E. Tissue culture studies of malignant effusions. Br. J. Cancer 1975, 32:512-518.
5. McGowan L., Davis R.H., Bunnag B. The biochemical diagnosis of ovarian cancer. Am. J. Obstet. Gynecol. 1973, 116:760-768.
6. Singh G., Dekker A., Ladoulis C.T. Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology. Acta Cytol. 1978, 22:487-489.
7. Monif G.R., Daly J.W. "Living cytology" in the diagnosis of intraabdominal adenocarcinoma. Obstet. Gynecol. 1975, 46:80-83.
8. Betjes M.G., Bos H.J., Krediet R.T., Arisz L. The mesothelial cells in CAPD effluent and their relation to peritonitis incidence. Perit. Dial. Int. 1991, 11:22-26.
9. Yanez-Mo M., Lara-Pezzi E., Selgas R., Ramirez-Huesca M., Dominguez-Jimenez C., Jimenez-Heffernan J.A., et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N. Engl. J. Med. 2003, 348:403-413.
10. Fang C.C., Yen C.J., Chen Y.M., Shyu R.S., Tsai T.J., Lee P.H., et al. Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: effects on TGF-beta. Kidney Int. 2000, 57:2626-2633.
11. Medcalf J.F., Walls J., Pawluczyk I.Z., Harris K.P. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): the role of TGF-beta. Nephrol. Dial. Transplant. 2001, 16:1885-1892.
12. Rampino T., Cancarini G., Gregorini M., Guallini P., Maggio M., Ranghino A., et al. Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. Am. J. Pathol. 2001, 159:1275-1285.
13. Foley-Comer A.J., Herrick S.E., Al-Mishlab T., Prele C.M., Laurent G.J., Mutsaers S.E. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J. Cell Sci. 2002, 115:1383-1389.
14. Lazarus A.H., Ellis J., Blanchette V., Freedman J., Sheng-Tanner X. Permeabilization and fixation conditions for intracellular flow cytometric detection of the T-cell receptor zeta chain and other intracellular proteins in lymphocyte subpopulations. Cytometry 1998, 32:206-213.
15. Mutsaers S.E. The mesothelial cell. Int. J. Biochem. Cell Biol. 2004, 36:9-16.
16. Yung S., Chan T.M. Intrinsic cells: mesothelial cells - central players in regulating inflammation and resolution. Perit. Dial. Int. 2009, 29(Suppl. 2):S21-27.
17. Yung S., Li F.K., Chan T.M. Peritoneal mesothelial cell culture and biology. Perit. Dial. Int. 2006, 26:162-173.
18. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009, 182:4499-4506.
19. Rodriguez P.C., Ochoa A.C. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 2008, 222:180-191.
20. Valle M.T., Degl'Innocenti M.L., Bertelli R., Facchetti P., Perfumo F., Fenoglio D., et al. Antigen-presenting function of human peritoneum mesothelial cells. Clin. Exp. Immunol. 1995, 101:172-176.
21. Hausmann M.J., Rogachev B., Weiler M., Chaimovitz C., Douvdevani A. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int. 2000, 57:476-486.
22. Rafii A., Mirshahi P., Poupot M., Faussat A.M., Simon A., Ducros E., et al. Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. PLoS One 2008, 3:e3894.
23. Martinet L., Poupot R., Mirshahi P., Rafii A., Fournie J.J., Mirshahi M., et al. Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses. Int. J. Cancer 2010, 126:2143-2152.
24. Pasquet M., Golzio M., Mery E., Rafii A., Benabbou N., Mirshahi P., et al. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int. J. Cancer 2010, 126:2090-2101.
25. Mutsaers S.E. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002, 7:171-191.
26. Lansley S.M., Searles R.G., Hoi A., Thomas C., Moneta H., Herrick S.E., et al. Mesothelial cell differentiation into osteoblast- and adipocyte-like cells. J. Cell Mol. Med. 2011, 15:2095-2105.
27. Herrick S.E., Mutsaers S.E. Mesothelial progenitor cells and their potential in tissue engineering. Int. J. Biochem. Cell Biol. 2004, 36:621-642.
28. Spaggiari G.M., Capobianco A., Abdelrazik H., Becchetti F., Mingari M.C., Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008, 111:1327-1333.
29. Bianco P., Robey P.G., Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008, 2:313-319.
30. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
31. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., Panasyuk A.F., Keiliss-Borok I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974, 17:331-340.
32. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
33. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 2000, 109:235-242.
34. In 't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., Noort W.A., Claas F.H., Willemze R., et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003, 102:1548-1549.
35. Gronthos S., Mankani M., Brahim J., Robey P.G., Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2000, 97:13625-13630.
36. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G. Circulating skeletal stem cells. J. Cell Biol. 2001, 153:1133-1140.
37. Tolar J., Le Blanc K., Keating A., Blazar B.R. Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 2010, 28:1446-1455.